Install
Where the world charts, chats and trades markets. We're a supercharged super-charting platform and social network for traders and investors. Free to sign up.
- 22,475articles · 30d
- 2+ day agolatest article
- Aug 14, 2026earliest in window
- 94%with images · 8 videos
- 143avg words
- business 12,876
- markets 10,798
- stock 7,737
- tmt newswire 6,073
- globenewswire 5,456
- finance 5,074
- technology 3,395
- stocks 3,393
- 2026 3,321
- economy 2,653
- earnings 2,544
- business news 2,315
- autre 2,077
- investing 2,022
- politics 1,822
- artificial intelligence 1,807
- results 1,624
- (midwest communications 1,604
- europe 1,530
- stock market 1,437
- Economy, Business & Finance 21,303
- Finance & Business 20,610
- News 12,653
- Finance 5,636
- Business & Industrial 2,338
- Industrial 614
- Health & Wellness 359
- Politics 266
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Google Just Made an AI Move That Could Matter Far More Than Wall Street Thinks
2+ day, 8+ hour ago (209+ words) Alphabet Inc. (GOOGL, Financials), the parent company of Google and one of the largest cloud and AI providers, is taking its infrastructure deeper into university research. Google Public Sector is partnering with Morgan State University to build an AI-focused research…...
PMN: Interim trial data show favorable safety and promising biomarker results for a new Alzheimer's antibody
2+ day, 10+ hour ago (81+ words) TradingView PMN: Interim trial data show favorable safety and promising biomarker results for a new Alzheimer's antibody A novel antibody therapy for Alzheimer's showed zero cases of brain swelling and strong biomarker engagement in a robust phase I-B trial, with…...
ARCT: Key clinical milestones for liver and lung mRNA therapies expected in the next 6–12 months
2+ day, 13+ hour ago (79+ words) TradingView Upcoming data readouts for liver (OTC deficiency) and lung (cystic fibrosis) mRNA programs are expected to shape the next year, with regulatory clarity and potential phase III advancement. The self-amplifying mRNA platform continues to generate revenue and attract interest…...
Europe's space chief raises need for the region to coordinate its satellite plans — TradingView News
2+ day, 14+ hour ago (27+ words) Europe's space chief raises need for the region to coordinate its satellite plans tradingview.com Europe's space chief raises need for the region to coordinate its satellite plans...
OriginTrail: OT-RFC-27 proposes a NeuroSymbolic Marketplace for TRAC-settled DKG queries and AI inference - 10 Sep 2026
2+ day, 15+ hour ago (121+ words) If the community approves the design, each paid query or inference task would route TRAC between nodes, creating recurring demand tied to actual usage of the knowledge graph rather than to staking alone. The metered settlement model would make token…...
AITX launches SARA Assess with Circadian Risk to extend agentic AI across third-party security systems
2+ day, 19+ hour ago (134+ words) TradingView AITX launches SARA Assess with Circadian Risk to extend agentic AI across third-party security systems Artificial Intelligence Technology Solutions announced commercial availability of SARA Assess, enabling SARA to connect with Circadian Risk to continuously verify security controls and trigger…...
KARD: Late-stage cardiovascular pipeline advances with adaptive trials and key data expected next year
3+ day, 10+ hour ago (72+ words) TradingView KARD: Late-stage cardiovascular pipeline advances with adaptive trials and key data expected next year A platform-focused cardiovascular innovator highlighted its late-stage pipeline in genetic cardiomyopathy and aortic stenosis, leveraging adaptive trial designs and real-world data integration. Key programs danicamtiv…...
Tevard Biosciences Announces Publication of Preclinical Research Supporting Engineered Suppressor tRNAs for Duchenne Muscular Dystrophy
3+ day, 11+ hour ago (96+ words) TradingView Tevard Biosciences Announces Publication of Preclinical Research Supporting Engineered Suppressor tRNAs for Duchenne Muscular Dystrophy - In a preclinical DMD model, engineered suppressor tRNA therapy restored physiological levels of full-length dystrophin, improved muscle strength and motor coordination, and was well…...
BEAM: Advancing pivotal gene editing programs with strong data, regulatory momentum, and platform scalability
3+ day, 11+ hour ago (73+ words) TradingView BEAM: Advancing pivotal gene editing programs with strong data, regulatory momentum, and platform scalability Significant pipeline progress includes pivotal trials for AATD and sickle cell, with strong clinical data and regulatory alignment for accelerated approval. The platform enables rapid…...
IRD: OPGX-BEST1 gene therapy showed robust safety and efficacy, supporting phase III advancement
3+ day, 13+ hour ago (85+ words) TradingView IRD: OPGX-BEST1 gene therapy showed robust safety and efficacy, supporting phase III advancement The phase I/II trial of OPGX-BEST1 gene therapy in BVMD and ARB showed strong safety and promising efficacy, with all participants experiencing functional gains and…...